Emerging Glycolysis Targeting and Drug Discovery from Chinese Medicine in Cancer Therapy
Molecular-targeted therapy has been developed for cancer chemoprevention and treatment. Cancer cells have different metabolic properties from normal cells. Normal cells mostly rely upon the process of mitochondrial oxidative phosphorylation to produce energy whereas cancer cells have developed an al...
Main Authors: | Zhiyu Wang, Neng Wang, Jianping Chen, Jiangang Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/873175 |
Similar Items
-
Targeting FASN in Breast Cancer and the Discovery of Promising Inhibitors from Natural Products Derived from Traditional Chinese Medicine
by: Chien-shan Cheng, et al.
Published: (2014-01-01) -
Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway
by: Yifeng Zheng, et al.
Published: (2019-01-01) -
Research advances of traditional Chinese medicine in cancer immunotherapy
by: Jing Li, et al.
Published: (2020-01-01) -
Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery
by: Qiang Sun, et al.
Published: (2021-07-01) -
YaTCM: Yet another Traditional Chinese Medicine Database for Drug Discovery
by: Baiqing Li, et al.
Published: (2018-01-01)